Results 241 to 250 of about 1,821,409 (281)

Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience

BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang, Mingzhao Li, Kai Yao, Zhuyinjun Zong, Yifan Chang, Yongda Liu, Chao Cai, Fadi Mousa Al Kalailah, Shancheng Ren, Guohua Zeng, Di Gu   +10 more
wiley   +1 more source

Repositioning Drugs for Psychiatry.

Avicenna journal of medical biotechnology
openaire   +1 more source

Drug repositioning: a brief overview [PDF]

Journal of Pharmacy and Pharmacology, 2020
International audienceAbstract Objectives Drug repositioning, that is, the use of a drug in an indication other than the one for which it was initially marketed, is a growing trend.
Christophe Rochais, Jean-Pierre Jourdan, Patrick Dallemagne   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Drug Repositioning in Oncology

American Journal of Therapeutics, 2021
Background: The worldwide increase in the occurrence of cancer associated with the limitations of immunotherapy and the emergence of resistance have impaired the prognosis of cancer patients, which leads to the search for alternative treatment methods.
Marissa B, Serafin, Angelita, Bottega, Taciéli F, da Rosa, Catrine S, Machado, Vitória S, Foletto, Silvana S, Coelho, Augusto D, da Mota, Rosmari, Hörner   +7 more
openaire   +2 more sources

Drug repositioning for orphan diseases [PDF]

Briefings in Bioinformatics, 2011
The need and opportunity to discover therapeutics for rare or orphan diseases are enormous. Due to limited prevalence and/or commercial potential, of the approximately 6000 orphan diseases (defined by the FDA Orphan Drug Act as
Anil Jegga, Minlu Zhang
exaly   +4 more sources

MeSHDD: Literature-based drug-drug similarity for drug repositioning

Journal of the American Medical Informatics Association: JAMIA, 2017
Objective: Drug repositioning is a promising methodology for reducing the cost and duration of the drug discovery pipeline. We sought to develop a computational repositioning method leveraging annotations in the literature, such as Medical Subject ...
Adam Brown, Chirag Patel
exaly   +2 more sources

Drug Repositioning on the Cloud

2011 IEEE Third International Conference on Cloud Computing Technology and Science, 2011
Market pressures have driven pharmaceutical companies to reassess their current drug development model and reach out to new innovative business models such as drug repositioning. Various techniques that are used in drug repositioning lend themselves to the distributed computing model. The \cloud is one such computing model that optimizes resource usage
Vassilis Virvilis, Anuj Sharma, Miltiadis Koutsokeras   +2 more
openaire   +1 more source

Off-Patent Drug Repositioning

Journal of Chemical Information and Modeling, 2020
Drug repositioning aims to reuse "old" drugs to treat diseases outside their approved indication(s). Composition-of-matter patents and FDA exclusivities can hinder the immediate availability of some drugs to be repositioned (repurposed). Here, we analyze data from the FDA Orange Book and use current on-market patent validity and exclusivities to ...
Sorin I. Avram, Ramona Curpan, Liliana Halip, Alina Bora, Tudor I. Oprea   +4 more
openaire   +4 more sources

Changing Trends in Computational Drug Repositioning [PDF]

Pharmaceuticals, 2018
Maximizing the indications potential and revenue from drugs that are already marketed offers a new take on the famous mantra of the Nobel Prize-winning pharmacologist, Sir James Black, “The most fruitful basis for the discovery of a new drug is to start with an old drug”.
Jaswanth Yella, Anil Jegga, Yunguan Wang   +2 more
exaly   +4 more sources

Network-based drug repositioning

Molecular BioSystems, 2013
Abstract Network-based computational biology, with the emphasis on biomolecular interactions and omics-data integration, has had success in drug development and created new directions such as drug repositioning and drug combination. Drug repositioning, i.e., revealing a drug's new roles, is increasingly attracting much attention from ...
Zikai, Wu, Yong, Wang, Luonan, Chen
openaire   +2 more sources